Prager, J, Ito, D, Carwardine, DR, Jiju, P, Chari, DM ORCID: https://orcid.org/0000-0002-7095-8578, Granger, N and Wong, L-F (2021) Delivery of chondroitinase by canine mucosal olfactory ensheathing cells alongside rehabilitation enhances recovery after spinal cord injury. Experimental Neurology, 340 (113660). 1- 14.

[img] Text
EXNR-20-1126_R1_accepted.pdf - Accepted Version
Restricted to Repository staff only until 26 February 2022.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB)

Abstract

Spinal cord injury (SCI) can cause chronic paralysis and incontinence and remains a major worldwide healthcare burden, with no regenerative treatment clinically available. Intraspinal transplantation of olfactory ensheathing cells (OECs) and injection of chondroitinase ABC (chABC) are both promising therapies but limited and unpredictable responses are seen, particularly in canine clinical trials. Sustained delivery of chABC presents a challenge due to its thermal instability; we hypothesised that transplantation of canine olfactory mucosal OECs genetically modified ex vivo by lentiviral transduction to express chABC (cOEC-chABC) would provide novel delivery of chABC and synergistic therapy. Rats were randomly divided into cOEC-chABC, cOEC, or vehicle transplanted groups and received transplant immediately after dorsal column crush corticospinal tract (CST) injury. Rehabilitation for forepaw reaching and blinded behavioural testing was conducted for 8 weeks. We show that cOEC-chABC transplanted animals recover greater forepaw reaching accuracy on Whishaw testing and more normal gait than cOEC transplanted or vehicle control rats. Increased CST axon sprouting cranial to the injury and serotonergic fibres caudal to the injury suggest a mechanism for recovery. We therefore demonstrate that cOECs can deliver sufficient chABC to drive modest functional improvement, and that this genetically engineered cellular and molecular approach is a feasible combination therapy for SCI.

Item Type: Article
Additional Information: The final version of this accepted manuscript and all relevant information related to it can be found online at; https://www.sciencedirect.com/science/article/pii/S0014488621000650?via%3Dihub
Subjects: R Medicine > RC Internal medicine > RC925 Diseases of the musculoskeletal system
Divisions: Faculty of Medicine and Health Sciences > School of Medicine
Depositing User: Symplectic
Date Deposited: 29 Apr 2021 13:50
Last Modified: 29 Apr 2021 13:50
URI: https://eprints.keele.ac.uk/id/eprint/9399

Actions (login required)

View Item View Item